JP2023521722A5 - - Google Patents
Info
- Publication number
- JP2023521722A5 JP2023521722A5 JP2022561133A JP2022561133A JP2023521722A5 JP 2023521722 A5 JP2023521722 A5 JP 2023521722A5 JP 2022561133 A JP2022561133 A JP 2022561133A JP 2022561133 A JP2022561133 A JP 2022561133A JP 2023521722 A5 JP2023521722 A5 JP 2023521722A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- unit
- patient
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20168405.7 | 2020-04-07 | ||
| EP20168405 | 2020-04-07 | ||
| EP20207528 | 2020-11-13 | ||
| EP20207528.9 | 2020-11-13 | ||
| PCT/EP2021/059117 WO2021204911A1 (en) | 2020-04-07 | 2021-04-07 | Neoepitope immunotherapy with apc targeting unit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521722A JP2023521722A (ja) | 2023-05-25 |
| JP2023521722A5 true JP2023521722A5 (https=) | 2024-04-16 |
Family
ID=75339769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561133A Pending JP2023521722A (ja) | 2020-04-07 | 2021-04-07 | Ａｐｃ標的化単位を用いたネオエピトープ免疫療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230147574A1 (https=) |
| EP (1) | EP4132959A1 (https=) |
| JP (1) | JP2023521722A (https=) |
| CN (1) | CN115698051A (https=) |
| AU (1) | AU2021253641A1 (https=) |
| CA (1) | CA3174417A1 (https=) |
| WO (1) | WO2021204911A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3183951A1 (en) * | 2020-07-14 | 2022-01-20 | Birgitte Rono | Apc targeting units for immunotherapy |
| US20250304626A1 (en) | 2021-05-26 | 2025-10-02 | Evaxion Biotech A/S | Vaccination targeting intracellular pathogens |
| US20250054576A1 (en) | 2021-12-17 | 2025-02-13 | Evaxion Biotech A/S | Personalized cancer therapy targeting normally non-expressed sequences |
| WO2024126758A2 (en) * | 2022-12-14 | 2024-06-20 | Ultimovacs Ab | A nucleic acid molecule and a chimeric polypeptide |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2335730A1 (en) * | 2009-12-18 | 2011-06-22 | Deutsches Krebsforschungszentrum | Fusion polypeptides and their use for prevention and treatment of cancer |
| JP2013532971A (ja) * | 2010-06-25 | 2013-08-22 | バッシボディ アクスイェ セルスカプ | ホモ二量体タンパク質コンストラクト |
| ES2970865T3 (es) | 2015-12-16 | 2024-05-31 | Gritstone Bio Inc | Identificación, fabricación y uso de neoantígenos |
| IL260030B2 (en) * | 2016-01-08 | 2025-12-01 | Nykode Therapeutics ASA | Therapeutic anticancer neoepitope vaccine |
| EP3452082A1 (en) * | 2016-05-04 | 2019-03-13 | Fred Hutchinson Cancer Research Center | Cell-based neoantigen vaccines and uses thereof |
| CA3060569A1 (en) | 2017-04-19 | 2018-10-25 | Gritstone Oncology, Inc. | Neoantigen identification, manufacture, and use |
| EP3678698A1 (en) * | 2017-09-07 | 2020-07-15 | University Of Oslo | Vaccine molecules |
| EP4576103A3 (en) | 2017-10-10 | 2025-08-27 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
| CN111630602A (zh) | 2017-11-22 | 2020-09-04 | 磨石肿瘤生物技术公司 | 减少新抗原的接合表位呈递 |
| AU2019215031C1 (en) * | 2018-01-31 | 2026-02-26 | Novartis Ag | Combination therapy using a chimeric antigen receptor |
-
2021
- 2021-04-07 US US17/995,601 patent/US20230147574A1/en active Pending
- 2021-04-07 WO PCT/EP2021/059117 patent/WO2021204911A1/en not_active Ceased
- 2021-04-07 AU AU2021253641A patent/AU2021253641A1/en active Pending
- 2021-04-07 EP EP21715937.5A patent/EP4132959A1/en active Pending
- 2021-04-07 CA CA3174417A patent/CA3174417A1/en active Pending
- 2021-04-07 CN CN202180037341.4A patent/CN115698051A/zh active Pending
- 2021-04-07 JP JP2022561133A patent/JP2023521722A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023521722A5 (https=) | ||
| JP2023533871A5 (https=) | ||
| AU2018203170B2 (en) | Multimeric Fusion Protein Vaccine And Immunotherapeutic | |
| CA2687395C (en) | Complement factor h-derived short consensus repeat-antibody constructs | |
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| RU97118145A (ru) | Внутриклеточный домен белка her-2/neu для предупреждения или лечения малигнизаций | |
| WO2001026608A2 (en) | Dna vaccines encoding antigen linked to a domain that binds cd40 | |
| US11352416B2 (en) | Mosaic chimeric viral vaccine particle | |
| JP2022529989A (ja) | フラジェリン融合タンパク質及びその使用 | |
| US20230355733A1 (en) | APC targeting units for immunotherapy | |
| JP2023521722A (ja) | Ａｐｃ標的化単位を用いたネオエピトープ免疫療法 | |
| CN118354785A (zh) | 靶向催化性补体活化分子及其使用方法 | |
| Gor et al. | Genetic fusion of three tandem copies of murine C3d sequences to diphtheria toxin fragment B elicits a decreased fragment B-specific antibody response | |
| JP2023546485A (ja) | Ｐｄ－ｌ１の細胞外ドメインを含むキメラ抗原 | |
| CN115197303B (zh) | 一种s蛋白的受体结合结构域的突变体及其应用 | |
| ES2719256T3 (es) | Proteínas de tipo superhélice modificadas que presentan unas propiedades mejoradas | |
| WO2025061682A1 (en) | Adenoviral targeting of dendritic cells |